Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Outlook Therapeutics (OTLK) Other Gross PP&E Adjustments (2016 - 2025)

Outlook Therapeutics has reported Other Gross PP&E Adjustments over the past 8 years, most recently at -$670807.0 for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 45.99% to -$670807.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$670807.0 through Dec 2025, up 45.99% year-over-year, with the annual reading at -$421131.0 for FY2025, 79.69% up from the prior year.
  • Other Gross PP&E Adjustments was -$670807.0 for Q4 2025 at Outlook Therapeutics, down from -$421131.0 in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at -$421131.0 in Q3 2025 and troughed at -$2.1 million in Q3 2024.